Category: Supply Chain

Texans find bare shelves in the cold medicine aisle amid omicron surge

The aisles for over-the-counter cough and cold medicines are nearly bare across Dallas Walmart, Target, CVS and Sam’s Club locations, The Dallas Morning News reported Jan. 10. 

FDA allows Florida to use 1M million expired COVID-19 tests

The FDA has extended the shelf life of nearly 1 million rapid COVID-19 test kits that first expired in a Florida warehouse in September, the Miami Herald reported Jan. 11. 

Red Cross declares nation’s first blood crisis

The American Red Cross, which supplies 40 percent of the nation’s blood, on Jan. 11 declared the first-ever national blood crisis. 

4 recent medical device recalls

Medical device recalls, whether voluntary or mandated by the FDA, ensure patient safety. 

Labs ration access to COVID-19 tests amid surge

The increasing demand for COVID-19 testing is prompting some labs across the U.S. to ration access and prioritize patients presenting symptoms or other health concerns, The Wall Street Journal reported Jan. 10.

COVID-19 treatments rationed & 7 more supply chain updates

Here are eight supply chain updates from the last two weeks: 

ECRI ranks 7 at-home COVID-19 tests for usability

ECRI, a nonprofit organization focused on patient safety and healthcare quality, released the first public ranking of commonly used at-home COVID-19 test kits based on usability. 

US resumes shipping antibody treatments that may be ineffective against omicron

The federal government has resumed shipping all three COVID-19 monoclonal antibody treatments to systems across the U.S. despite evidence two of the three may be ineffective in treating omicron, The Washington Post reported Jan. 9. 

Kansas hospital out of ventilators, sparks local emergency declaration

Lyon County (Kan.) declared a local emergency Jan. 7 after Newman Regional Hospital ran out of ventilators, The Kansas City Star reported. 

White House, USPS solidify plans to distribute 500M COVID-19 tests

The U.S. government is finalizing a plan with the U.S. Postal Service to distribute 500 million COVID-19 tests to households nationwide, four people familiar with the matter told The Washington Post.